Hao‐Hsien Lee
Papers
1
Total Citations
6
H-Index
1
About
Hao‐Hsien Lee is a distinguished clinical researcher whose work centers on hepatobiliary surgery, patient-reported outcomes, and longitudinal quality-of-life (QOL) assessment in hepatocellular carcinoma (HCC) care. His most impactful contribution is a landmark 2022 prospective cohort study employing inverse probability of treatment weighting to compare five-year QOL trajectories across three surgical procedures for HCC. By analyzing individual subscales of QOL measures in 520 patients, Lee demonstrated that surgical choice significantly influences long-term well-being, identifying key predictors of effective recovery. This work has garnered 6 citations and provides surgeons with evidence-based guidance for shared decision-making. Lee’s research uniquely bridges surgical oncology and patient-centered outcomes, offering nuanced insights into how different procedures affect physical, emotional, and social functioning over time. His methodological rigor—particularly the use of advanced weighting techniques to reduce selection bias—has set a new standard for comparative effectiveness studies in hepatobiliary surgery. For students and researchers, Lee’s work exemplifies how rigorous longitudinal designs can transform clinical practice by prioritizing what matters most to patients: not just survival, but quality of life.
Research Focus
Key Achievements
Top Papers
- 1